A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
AADAC | Arylacetamide deacetylase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
AC234582.2 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM6 | Acyl-CoA synthetase medium-chain family member 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AL021546.6 | Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial {ECO:0000313|Ensembl:ENSP00000229384} | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD22 | Ankyrin repeat domain 22 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT8 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT2 | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BACE2 | Beta-site APP-cleaving enzyme 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BAIAP2L2 | BAI1-associated protein 2-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCO1 | Beta-carotene oxygenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BRINP3 | Bone morphogenetic protein/retinoic acid inducible neural-specific 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BTNL2 | Butyrophilin-like 2 (MHC class II associated) | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2orf72 | Chromosome 2 open reading frame 72 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf222 | Chromosome 6 open reading frame 222 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| | | | | Tissue enhanced |